Effect of Herbal Mixture as Angiotensin Converting Enzyme Inhibitor in Angiotensin-II Dependent Hypertension

被引:4
|
作者
Farieha [1 ]
Jahan, Nazish [1 ]
Khalil-ur-Rahman [2 ]
Ali, Shaukat [1 ]
机构
[1] Univ Agr Faisalabad, Dept Chem, Faisalabad 38040, Pakistan
[2] Univ Agr Faisalabad, Dept Biochem, Faisalabad 38040, Pakistan
关键词
ACE; Blood pressure; Curcuma longa; Hematological parameters; Rauvolfia serpentine; Synergism; BLOOD-PRESSURE; IMMUNOMODULATORY ACTIVITY; ACE-INHIBITORS; ESSENTIAL OILS; EXTRACT; COCCIDIOSIS; DISEASE;
D O I
10.29261/pakvetj/2018.103
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The effect of herbal mixture of Curcuma longa (CL) and Rauvolfia serpentina (RS) as green ACE inhibitors in Angiotensin-II dependent hypertension was evaluated by measuring the changes in ACE level in blood serum of hypertensive dogs. 2K1C Renovascular Hypertension Model (RVHM) was used to introduce hypertension in dogs. Substantial Hypertension was induced after seven days of renal artery ligation (RAL) with significant increase in the level of ACE in blood serum of spontaneously hypertensive dogs (SHD). Experimental dogs were divided into four groups among them RVH hypertension was induced in the dogs of three groups and fourth group was the normotensive dogs. Hypertensive dogs of one group left untreated while the other two groups treated with herbal mixture and standard drug (Captopril) respectively. The herbal mixture showed significant decrease in Systolic blood pressure (SBP) pressure, diastolic blood pressure (DBP), Pulse rate (PR), and serum ACE level of SHD as compared to Captopril. SBP, DBP and PR were also correlated with hematological parameters. Daily oral administration of herbal mixture resulted in a time-dependent blood pressure and ACE level reduction in SHD, with management of hypertension after nine days treatment. White blood cells (WBC), Lymphocyte (LYM), Mid-sized cells (MID), Granulocyte (GRA), platelet count (PLT), mean corpuscular volume (MPV), platelet distribution width (PDW) and platelet crit (PCT) showed highly significant (P<0.01) positive correlation with SBP, DBP and PR while (red blood cells) RBC showed significant (P<0.05) positive correlation only with SBP and PR. This study demonstrated that the combination of CL and RS effectively reduced blood pressure and heart rate of SHD and this antihypertensive effect is probably due to the reduction of ACE level in blood serum. (C) 2018 PVJ. All rights reserved
引用
收藏
页码:25 / 30
页数:6
相关论文
共 50 条
  • [1] Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2 Prevention of Angiotensin II-Dependent Hypertension
    Wysocki, Jan
    Ye, Minghao
    Rodriguez, Eva
    Gonzalez-Pacheco, Francisco R.
    Barrios, Clara
    Evora, Karla
    Schuster, Manfred
    Loibner, Hans
    Brosnihan, K. Bridget
    Ferrario, Carlos M.
    Penninger, Josef M.
    Batlle, Daniel
    HYPERTENSION, 2010, 55 (01) : 90 - U160
  • [2] Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension
    Tikkanen, I
    Omvik, P
    Jensen, HA
    JOURNAL OF HYPERTENSION, 1995, 13 (11) : 1343 - 1351
  • [3] Angiotensin-Converting Enzyme-Derived Angiotensin II Formation During Angiotensin II-Induced Hypertension
    Gonzalez-Villalobos, Romer A.
    Satou, Ryousuke
    Seth, Dale M.
    Semprun-Prieto, Laura C.
    Katsurada, Akemi
    Kobori, Hiroyuki
    Navar, L. Gabriel
    HYPERTENSION, 2009, 53 (02) : 351 - 355
  • [4] Angiotensin-converting enzyme and metals in untreated essential hypertension
    Ekmekci, OB
    Donma, O
    Tunckale, A
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2003, 95 (03) : 203 - 210
  • [5] Relationship between the response to the angiotensin converting enzyme inhibitor imidapril and the angiotensin converting enzyme genotype
    Ohmichi, N
    Iwai, N
    Uchida, Y
    Shichiri, G
    Nakamura, Y
    Kinoshita, M
    AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (08) : 951 - 955
  • [6] SYNERGISTIC EFFECT ON REDUCTION IN BLOOD-PRESSURE WITH COADMINISTRATION OF A RENIN INHIBITOR OR AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR WITH AN ANGIOTENSIN-II RECEPTOR ANTAGONIST
    FOSSA, AA
    DEPASQUALE, MJ
    RINGER, LJ
    WINSLOW, RL
    DRUG DEVELOPMENT RESEARCH, 1994, 33 (04) : 422 - 428
  • [7] Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients
    Hasvold, L. P.
    Bodegard, J.
    Thuresson, M.
    Stalhammar, J.
    Hammar, N.
    Sundstrom, J.
    Russell, D.
    Kjeldsen, S. E.
    JOURNAL OF HUMAN HYPERTENSION, 2014, 28 (11) : 663 - 669
  • [8] SYMPATHETIC-NERVE ACTIVITY IN CONSCIOUS RENAL HYPERTENSIVE RATS TREATED WITH AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR OR AN ANGIOTENSIN-II ANTAGONIST
    NIEDERBERGER, M
    AUBERT, JF
    NUSSBERGER, J
    BRUNNER, HR
    WAEBER, B
    JOURNAL OF HYPERTENSION, 1995, 13 (04) : 439 - 445
  • [9] ENDOGENOUS ANGIOTENSINS, ANGIOTENSIN-II COMPETITIVE-BINDING INHIBITORS AND CONVERTING-ENZYME-INHIBITOR IN ELASMOBRANCH FISH
    HAZON, N
    TIERNEY, M
    HAMANO, K
    ASHIDA, K
    TAKEI, Y
    NETHERLANDS JOURNAL OF ZOOLOGY, 1995, 45 (1-2): : 117 - 120
  • [10] Response to the letter to the editor entitled 'Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic'
    Bottino, Leonardo Grabinski
    Fuchs, Flavio Danni
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2021, 19 (02) : 189 - 190